| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |